the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy

This study is currently recruiting participants.
Verified June 2012 by Tehran University of Medical Sciences
Sponsor:
Information provided by (Responsible Party):
Babak Saedi, Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00497588
First received: July 4, 2007
Last updated: June 2, 2012
Last verified: June 2012

July 4, 2007
June 2, 2012
March 2007
December 2012   (final data collection date for primary outcome measure)
quality of voice [ Time Frame: 3 to 6 month after therapy ] [ Designated as safety issue: No ]
quality of voice [ Time Frame: 3 to 6 month after therapy ]
Complete list of historical versions of study NCT00497588 on ClinicalTrials.gov Archive Site
quality of life [ Time Frame: 6 month later ] [ Designated as safety issue: No ]
quality of life [ Time Frame: 6 month later ]
 
 
 
the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy
 

early laryngeal cancer is a well known field with great controversy in treatment. two options are available in treatment of patients the first one is partial laryngectomy and the second one is radiotherapy.one of major concern of patients have been the quality of voice ,so we design this trial to answer the priority of each options.

early laryngeal cancer is a well known field with great controversy in treatment. two options are available in treatment of patients the first one is partial laryngectomy and the second one is radiotherapy.one of major concern of patients have been the quality of voice as part of quality of life ,so we design this clinical randomised trial to answer the priority of each options.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Voice Quality
  • Procedure: surgery
  • Radiation: radiotherapy
  • Active Comparator: radiotherapy
    patients receive radiotherapy
    Intervention: Radiation: radiotherapy
  • Experimental: surgery
    Patients undergo surgery
    Intervention: Procedure: surgery
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
33
December 2012
December 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Early laryngeal cancer

Exclusion Criteria:

  • No history of radiotherapy and collagen vascular disease
Both
 
No
Contact: babak saedi, professor 98219123872469 saedi@tums.ac.ir
Contact: mohamad sadeghi, professor 98219121153594 sadeghi@tums.ac.ir
Iran, Islamic Republic of
 
NCT00497588
bs-86-01-48-5497
Yes
Babak Saedi, Tehran University of Medical Sciences
Tehran University of Medical Sciences
 
Principal Investigator: babak saedi, professor tehran university of medical science
Tehran University of Medical Sciences
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP